Kfin Technologies DuPont analysis

·Banking & FinanceChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
0.73×0.73×0.74×0.75×0.76×
1.05×1.06×1.08×1.05×1.03×
31.0%34.1%38.0%37.4%34.9%
0.58×0.58×0.69×0.63×0.58×
1.75×1.66×1.24×1.24×1.44×
24.0%25.4%26.2%23.0%22.7%
22.3%22.3%26.1%24.5%22.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

KFINTECH₹859.80

Kfin Technologies Ltd.

· Banking & Finance
₹ CrorePeersCAMSMANAPPURAMKARURVYSYAIIFLFIVESTARCUBPIRAMALFINPNBHOUSINGMcap ₹14,834 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.760.750.740.730.73
Interest Burden (Pretax/EBIT) ×1.031.051.081.061.05
EBIT Margin %34.9137.4438.0134.0730.96
Asset Turnover ×0.580.630.690.580.58
Financial Leverage (Assets/Equity) ×1.441.241.241.661.75
ROE (5-step product, year-end total equity) %22.6723.0126.1725.3923.97
ROE (owners' profit / average owners' equity) %22.4924.4726.1022.3122.31
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.